Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Clinical trial NCT06844500 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06844500
Sponsor: Jean-Pierre Van geertruyden
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neonate Maternal Transmission Mpox Vaccination Immunogenicity Safety Pregnancy Postpartum

Start date: 2025-06-23
Primary completion: 2026-06-01
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.